Your browser doesn't support javascript.
loading
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
Hodge, Daryl; Marra, Fiona; Marzolini, Catia; Boyle, Alison; Gibbons, Sara; Siccardi, Marco; Burger, David; Back, David; Khoo, Saye.
Affiliation
  • Hodge D; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Marra F; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Marzolini C; Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Boyle A; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Gibbons S; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, Basel, Switzerland.
  • Siccardi M; University of Basel, Basel, Switzerland.
  • Burger D; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Back D; Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Khoo S; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
J Antimicrob Chemother ; 75(12): 3417-3424, 2020 12 01.
Article de En | MEDLINE | ID: mdl-32750131

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Pneumopathie virale / Infections à coronavirus / Traitements en cours d'évaluation / Interactions médicamenteuses / Betacoronavirus Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Antimicrob Chemother Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Pneumopathie virale / Infections à coronavirus / Traitements en cours d'évaluation / Interactions médicamenteuses / Betacoronavirus Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Antimicrob Chemother Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni